On August 5, 2025, Vivani Medical, Inc. reported preliminary financials showing approximately $6.8 million in cash as of June 30, 2025, with an additional $11.25 million expected from equity agreements, alongside positive clinical results for their NPM-139 and NPM-115 implants for weight loss treatments.